At-home transcranial direct current stimulation for Alzheimer's patients
Longitudinal Study Examining At-Home Transcranial Direct Current Stimulation
NA · Lady Davis Institute · NCT04524338
This study is testing whether Alzheimer's patients can safely use a special brain stimulation device at home to see if it helps improve their thinking skills.
Quick facts
| Phase | NA |
|---|---|
| Study type | Interventional |
| Enrollment | 20 (estimated) |
| Ages | 50 Years to 100 Years |
| Sex | All |
| Sponsor | Lady Davis Institute (other) |
| Locations | 1 site (Montreal, Quebec) |
| Trial ID | NCT04524338 on ClinicalTrials.gov |
What this trial studies
This study assists individuals with Alzheimer's disease or other forms of dementia in obtaining and using their own transcranial direct current stimulation (tDCS) machines at home. Participants will receive guidance on purchasing the appropriate equipment and training on how to administer tDCS safely and effectively. Monthly reports will be collected to monitor the participants' conditions and any improvements in their cognitive abilities. The study aims to provide a supportive framework for those who have previously benefited from tDCS in a clinical setting but are unable or unwilling to continue in formal research studies.
Who should consider this trial
Good fit: Ideal candidates are individuals diagnosed with Alzheimer's disease or other forms of dementia who are interested in self-administering tDCS.
Not a fit: Patients with contraindications such as metal in the head or other safety concerns will not benefit from this study.
Why it matters
Potential benefit: If successful, this approach could empower patients to manage their cognitive symptoms more effectively at home.
How similar studies have performed: Previous studies have shown promising results with tDCS in improving cognitive functions in dementia patients, indicating potential for success in this approach.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Diagnosis of Alzheimer's Disease or other form of dementia (e.g., Primary Progressive Aphasia) Exclusion Criteria: * Metal in the head or other factors that would make stimulation unsafe
Where this trial is running
Montreal, Quebec
- Perform Centre — Montreal, Quebec, Canada (RECRUITING)
Study contacts
- Principal investigator: Carlos Roncero, PhD — Baycrest
- Study coordinator: Shelley Solomon
- Email: shelley.solomon2@mail.mcgill.ca
- Phone: 514-340-8222
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: Alzheimer Disease, Transcranial Direct Current Stimulation